1. A New Histone Deacetylase Inhibitor, MHY4381, Induces Apoptosis via Generation of Reactive Oxygen Species in Human Prostate Cancer Cells
   Sachan Richa et al, 2020, Biomolecules & Therapeutics CrossRef
2. Suberoylanilide Hydroxamic Acid (SAHA) Treatment Reveals Crosstalk Among Proteome, Phosphoproteome, and Acetylome in Nasopharyngeal Carcinoma Cells
   Huichao Huang et al, 2022, Frontiers in Genetics CrossRef
3. Ultradeep Lysine Crotonylome Reveals the Crotonylation Enhancement on Both Histones and Nonhistone Proteins by SAHA Treatment
   Quan Wu et al, 2017, Journal of Proteome Research CrossRef
4. Anticancer potential of indole derivatives: an update
   Shashi Kiran Misra et al, 2023, Physical Sciences Reviews CrossRef
5. Hyaluronic Acid-Functionalized Nanomicelles Enhance SAHA Efficacy in 3D Endometrial Cancer Models
   Kadie Edwards et al, 2021, Cancers CrossRef
6. Epigenetic Reprogramming in Lung Carcinomas
   András Kádár et al, 2012, Patho-Epigenetics of Disease CrossRef
7. Histone Deacetylase Inhibition and Autophagy Modulation Induces a Synergistic Antiproliferative Effect and Cell Death in Cholangiocarcinoma Cells
   Münevver Yenigül et al, 2023, ACS Omega CrossRef
8. Revisiting Glycogen in Cancer: A Conspicuous and Targetable Enabler of Malignant Transformation
   Tashbib Khan et al, 2020, Frontiers in Oncology CrossRef
9. Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets
   Khuloud Bajbouj et al, 2021, International Journal of Molecular Sciences CrossRef
10. Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model
    Akihiko Miyanaga et al, 2008, Molecular Cancer Therapeutics CrossRef